Literature DB >> 6428645

Diabetogenic effects of nifedipine.

S K Bhatnagar, M M Amin, A R Al-Yusuf.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6428645      PMCID： PMC1442075          DOI： 10.1136/bmj.289.6436.19

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN： 0267-0623


× No keyword cloud information.
  3 in total

1.  Hyperglycaemic effect of nifedipine.

Authors:  S Charles; J M Ketelslegers; M Buysschaert; A E Lambert
Journal:  Br Med J (Clin Res Ed)       Date:  1981-07-04

2.  Impairment of insulin secretion in man by nifedipine.

Authors:  D Giugliano; R Torella; F Cacciapuoti; S Gentile; M Verza; M Varricchio
Journal:  Eur J Clin Pharmacol       Date:  1980-11       Impact factor: 2.953

3.  Effect of nifedipine on glucose tolerance and insulin secretion in diabetic and non-diabetic patients.

Authors:  T Donnelly; A D Harrower
Journal:  Curr Med Res Opin       Date:  1980       Impact factor: 2.580
  3 in total
  16 in total

Review 1.  Effects of drugs on glucose tolerance in non-insulin-dependent diabetics (Part II).

Authors:  S O'Byrne; J Feely
Journal:  Drugs       Date:  1990-08       Impact factor: 9.546

Review 2.  Nifedipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in ischaemic heart disease, hypertension and related cardiovascular disorders.

Authors:  E M Sorkin; S P Clissold; R N Brogden
Journal:  Drugs       Date:  1985-09       Impact factor: 9.546

Review 3.  Calcium channel blocking agents and the heart.

Authors:  J Kenny
Journal:  Br Med J (Clin Res Ed)       Date:  1985-10-26

4.  ACE-inhibition increases hepatic and extrahepatic sensitivity to insulin in patients with type 2 (non-insulin-dependent) diabetes mellitus and arterial hypertension.

Authors:  E Torlone; A M Rambotti; G Perriello; G Botta; F Santeusanio; P Brunetti; G B Bolli
Journal:  Diabetologia       Date:  1991-02       Impact factor: 10.122

5.  Disposition and hypoglycaemic action of glipizide in diabetic patients given a single dose of nifedipine.

Authors:  A A Connacher; A H el Debani; T E Isles; I H Stevenson
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

6.  Glucose tolerance in hypertensive patients during treatment with the calcium antagonist, felodipine.

Authors:  T Hedner; D Elmfeldt; H Von Schenck; E Sjögren; U Smith
Journal:  Br J Clin Pharmacol       Date:  1987-08       Impact factor: 4.335

7.  Antihypertensive and metabolic effects of nifedipine and labetalol alone and in combination in primary hypertension.

Authors:  K P Ohman; L Weiner; H von Schenck; B E Karlberg
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

8.  Lack of effect of long-term amlodipine on insulin sensitivity and plasma insulin in obese patients with essential hypertension.

Authors:  M de Courten; P Ferrari; M Schneider; L Böhlen; S Shaw; W Riesen; G Heynen; P Weidmann
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

9.  Lack of effect of nicardipine and diltiazem on glucose- and arginine-induced insulin release in obese subjects.

Authors:  A Pezzarossa; M C Cimicchi; N Orlandi; A Gnudi; C Manca; A Perrone; R Bolognesi
Journal:  Cardiovasc Drugs Ther       Date:  1988-12       Impact factor: 3.727

Review 10.  Calcium channel antagonists. Part IV: Side effects and contraindications drug interactions and combinations.

Authors:  L H Opie
Journal:  Cardiovasc Drugs Ther       Date:  1988-07       Impact factor: 3.727
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.